LSA
VRTX icon

Leonteq Securities AG’s Vertex Pharmaceuticals VRTX Stock Holding History

Leonteq Securities AG’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.2M Buy
4,433
+173
+4% +$76.7K 0.08% 171
2026
Q1 		$1.9M Sell
4,260
-766
-15% -$357K 0.07% 204
2025
Q4 		$2.28M Sell
5,026
-2,002
-28% -$863K 0.07% 203
2025
Q3 		$2.75M Buy
7,028
+2,473
+54% +$1.03M 0.08% 166
2025
Q2 		$2.03M Sell
4,555
-1,265
-22% -$583K 0.08% 159
2025
Q1 		$2.8M Sell
5,820
-836
-13% -$390K 0.16% 125
2024
Q4 		$2.68M Buy
6,656
+2,285
+52% +$1.06M 0.18% 120
2024
Q3 		$2.03M Sell
4,371
-1,262
-22% -$606K 0.15% 132
2024
Q2 		$2.64M Buy
5,633
+245
+5% +$106K 0.19% 103
2024
Q1 		$2.25M Sell
5,388
-695
-11% -$294K 0.17% 135
2023
Q4 		$2.48M Buy
6,083
+4,001
+192% +$1.48M 0.14% 140
2023
Q3 		$724K Sell
2,082
-277
-12% -$96.9K 0.04% 298
2023
Q2 		$830K Buy
2,359
+400
+20% +$135K 0.04% 305
2023
Q1 		$617K Sell
1,959
-747
-28% -$224K 0.03% 333
2022
Q4 		$781K Sell
2,706
-11
-0.4% -$3.35K 0.03% 315
2022
Q3 		$787K Sell
2,717
-390
-13% -$112K 0.03% 303
2022
Q2 		$876K Sell
3,107
-2,549
-45% -$682K 0.03% 305
2022
Q1 		$1.48M Sell
5,656
-8,064
-59% -$1.91M 0.05% 234
2021
Q4 		$3.01M Sell
13,720
-27,760
-67% -$5.4M 0.11% 161
2021
Q3 		$7.52M Buy
41,480
+15,666
+61% +$3.06M 0.32% 79
2021
Q2 		$5.2M Buy
25,814
+2,925
+13% +$612K 0.31% 67
2021
Q1 		$4.92M Buy
22,889
+14,598
+176% +$3.21M 0.29% 79
2020
Q4 		$1.96M Buy
+8,291
New +$1.9M 0.1% 165

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Leonteq Securities AG's VRTX Position: Q2 2026 in Review

Leonteq Securities AG increased its Vertex Pharmaceuticals (VRTX) stake by 4.1% in Q2 2026, buying an estimated $76.7K and bringing the position to 4,433 shares worth $2.2M. The position accounts for 0.08% of the portfolio, ranked #171.

Leonteq Securities AG first reported a position in VRTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $7.52M in Q3 2021. 1,743 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Leonteq Securities AG held 4,433 shares of Vertex Pharmaceuticals worth $2.2M as of Q2 2026.
  • Leonteq Securities AG bought 173 Vertex Pharmaceuticals shares in Q2 2026, an estimated $76.7K.
  • Vertex Pharmaceuticals made up 0.08% of Leonteq Securities AG's portfolio in Q2 2026, its #171 holding.
  • Leonteq Securities AG first reported a position in Vertex Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Vertex Pharmaceuticals position peaked at $7.52M in Q3 2021.
  • 1,743 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.